| RFC3 |
RFC3: Replication factor C subunit 3 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
19.030 |
Evidence |
|
| RFC5 |
RFC5: Replication factor C subunit 5 |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
19.030 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
NFIL3 |
NFIL3, E4BP4, IL3BP1: Nuclear factor interleukin-3-regulated protein |
19.030 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
NMI |
NMI: N-myc-interactor |
19.030 |
Evidence |
|
| WASPIP |
IPI00552369 |
SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
19.030 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
STAT3 |
|
19.020 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
19.020 |
Evidence |
|
| C1QC |
C1QC, C1QG: Complement C1q subcomponent subunit C precursor |
APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
19.020 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
OPTC |
OPTC, OPT: Opticin precursor |
19.020 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
19.020 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
RAC1 |
IPI00219675 |
18.960 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EP300 |
IPI00478752 |
18.960 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
CDX2 |
CDX2, CDX3: Homeobox protein CDX-2 |
18.930 |
Evidence |
|
| ATM |
ATM: Serine-protein kinase ATM |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
18.930 |
Evidence |
|
| STK4 |
STK4, MST1: Serine/threonine-protein kinase 4 |
RIN1 |
RIN1: Ras and Rab interactor 1 |
18.930 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
HIPK3 |
HIPK3, DYRK6, FIST3, PKY: Homeodomain-interacting protein kinase 3 |
18.930 |
Evidence |
|
| CCNH |
CCNH: Cyclin-H |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
18.930 |
Evidence |
|
| CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
18.930 |
Evidence |
|
| PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
RIN1 |
RIN1: Ras and Rab interactor 1 |
18.930 |
Evidence |
|
| GRIA4 |
GRIA4, GLUR4: Glutamate receptor 4 precursor |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
18.930 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CDK5 |
CDK5: Cell division protein kinase 5 |
18.930 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
RPS6KB2 |
RPS6KB2, STK14B: Ribosomal protein S6 kinase beta-2 |
18.930 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
SH3BP5 |
IPI00006776 |
18.930 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
18.930 |
Evidence |
O
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
PTPRB |
PTPRB, PTPB: Receptor-type tyrosine-protein phosphatase beta precursor |
18.930 |
Evidence |
|